AAAAAA

   
Results: 1-14 |
Results: 14
INDUCTION CHEMOTHERAPY FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION OR AGGRESSIVE CONSOLIDATION CHEMOTHERAPY IN CHILDHOOD ACUTE MYELOBLASTIC-LEUKEMIA - A PROSPECTIVE-STUDY FROM THE NCH-SOCIETY-OF-PEDIATRIC-HEMATOLOGY-AND-IMMUNOLOGY (SHIP)
Authors: MICHEL G BARUCHEL A TABONE MD NELKEN B LEBLANC T THURET I BORDIGONI P BERGERON C ESPEROUBOURDEAU H PEREL Y VANNIER JP DELUMLEY L DOMMERGUES JP LAMAGNERE JP COUILLAUD G AUVRIGNON A SCHAISON G LEVERGER G
Citation: G. Michel et al., INDUCTION CHEMOTHERAPY FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION OR AGGRESSIVE CONSOLIDATION CHEMOTHERAPY IN CHILDHOOD ACUTE MYELOBLASTIC-LEUKEMIA - A PROSPECTIVE-STUDY FROM THE NCH-SOCIETY-OF-PEDIATRIC-HEMATOLOGY-AND-IMMUNOLOGY (SHIP), HEM CELL TH, 38(2), 1996, pp. 169-176
RETROSPECTIVE EVALUATION OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION VSALLOGENEIC BONE-MARROW TRANSPLANTATION FROM AN HLA IDENTICAL RELATED DONOR IN ACUTE MYELOCYTIC-LEUKEMIA - A STUDY OF THE ERATIVE-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT)
Authors: GORIN NC LABOPIN M FOUILLARD L MELONI G FRASSONI F IRIONDO A MAURI SB GOLDSTONE AH HAROUSSEAU JL REIFFERS J ESPEROUBOURDEAU H GLUCKMAN E
Citation: Nc. Gorin et al., RETROSPECTIVE EVALUATION OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION VSALLOGENEIC BONE-MARROW TRANSPLANTATION FROM AN HLA IDENTICAL RELATED DONOR IN ACUTE MYELOCYTIC-LEUKEMIA - A STUDY OF THE ERATIVE-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT), Bone marrow transplantation, 18(1), 1996, pp. 111-117
ALLOGENEIC BONE-MARROW TRANSPLANTATION VS AGGRESSIVE POSTREMISSION CHEMOTHERAPY FOR CHILDREN WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION - A PROSPECTIVE-STUDY FROM THE NCH-SOCIETY-OF-PEDIATRIC-HEMATOLOGY-AND-IMMUNOLOGY (SHIP)
Authors: MICHEL G LEVERGER G LEBLANC T NELKEN B BARUCHEL A LANDMANPARKER J THURET I BERGERON C BORDIGONI P ESPEROUBOURDEAU H PEREL Y VANNIER JP SCHAISON G
Citation: G. Michel et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION VS AGGRESSIVE POSTREMISSION CHEMOTHERAPY FOR CHILDREN WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION - A PROSPECTIVE-STUDY FROM THE NCH-SOCIETY-OF-PEDIATRIC-HEMATOLOGY-AND-IMMUNOLOGY (SHIP), Bone marrow transplantation, 17(2), 1996, pp. 191-196
AN OUTBREAK OF INVASIVE ASPERGILLOSIS AMONG BONE-MARROW TRANSPLANTS -CLINICAL-RESULTS AND EPIDEMIOLOGIC FINDINGS
Authors: PARQUET N RIBAUD P CHASTANG C LATGE JP SARFATI J BAFFROYLAFITTE L DEVERGIE A ESPEROUBOURDEAU H TRAORE F BOUAKLINE A DEKERVILER E GLUCKMAN E
Citation: N. Parquet et al., AN OUTBREAK OF INVASIVE ASPERGILLOSIS AMONG BONE-MARROW TRANSPLANTS -CLINICAL-RESULTS AND EPIDEMIOLOGIC FINDINGS, Experimental hematology, 23(8), 1995, pp. 856-856
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOLLOWING A BUSULFAN-BASED CONDITIONING REGIMEN IN YOUNG-CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A COOPERATIVE STUDY OF THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE
Authors: VONBUELTZINGSLOEWEN A ESPEROUBOURDEAU H SOUILLET G DEMEOCQ F MECHINAUDLACROIX F MICHEL G SADOUN A BERNAUDIN F CORNU G DONADIEU J RUBIE H RORLICH P LACOUR B GLUCKMAN E BORDIGONI P
Citation: A. Vonbueltzingsloewen et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOLLOWING A BUSULFAN-BASED CONDITIONING REGIMEN IN YOUNG-CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A COOPERATIVE STUDY OF THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE, Bone marrow transplantation, 16(4), 1995, pp. 521-527
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - IMPACT OF CONDITIONING REGIMEN WITHOUT TOTAL-BODY IRRADIATION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE
Authors: MICHEL G GLUCKMAN E ESPEROUBOURDEAU H REIFFERS J PICO JL BORDIGONI P THURET I BLAISE D BERNAUDIN F JOUET JP LEMERLE S RUBIE H MILPIED N VANNIER JP DEMEOCQ F TROUSSARD X GRATECOS N PLOUVIER E BERGERON C GARDEMBAS M GOUVERNET J MARANINCHI D
Citation: G. Michel et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - IMPACT OF CONDITIONING REGIMEN WITHOUT TOTAL-BODY IRRADIATION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE, Journal of clinical oncology, 12(6), 1994, pp. 1217-1222
INVASIVE ASPERGILLOSIS AND ALLOGENEIC BON E-MARROW TRANSPLANTATION
Authors: RIBAUD P ESPEROUBOURDEAU H DEVERGIE A GLUCKMAN E
Citation: P. Ribaud et al., INVASIVE ASPERGILLOSIS AND ALLOGENEIC BON E-MARROW TRANSPLANTATION, Pathologie et biologie, 42(7), 1994, pp. 652-655
COMPARISON OF ALLOGENEIC AND AUTOLOGOUS TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN CHILDREN AND ADULTS
Authors: GLUCKMAN E LABOPIN M ESPEROUBOURDEAU H GORIN NC
Citation: E. Gluckman et al., COMPARISON OF ALLOGENEIC AND AUTOLOGOUS TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN CHILDREN AND ADULTS, Experimental hematology, 22(8), 1994, pp. 765-765
MALIGNANT DISEASES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - AN UPDATED OVERVIEW
Authors: SOCIE G HENRYAMAR M DEVERGIE A ESPEROUBOURDEAU H RIBAUD P TRAINEAU R GLUCKMAN E
Citation: G. Socie et al., MALIGNANT DISEASES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - AN UPDATED OVERVIEW, Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000075-190000077
PROGRESS IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: DEVERGIE A TRAINEAU R ESPEROUBOURDEAU H RIBAUD P SOCIE G RICHARD P SELIMI F HIRSCH I GLUCKMAN E
Citation: A. Devergie et al., PROGRESS IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000089-190000090
COMPARISON OF ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOCYTIC-LEUKEMIA (AML) IN EUROPE AN EBMT SURVEY
Authors: GORIN NC LABOPIN M ESPEROUBOURDEAU H GLUCKMAN E
Citation: Nc. Gorin et al., COMPARISON OF ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOCYTIC-LEUKEMIA (AML) IN EUROPE AN EBMT SURVEY, Blood, 84(10), 1994, pp. 10000211-10000211
USE OF AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY FOR GVHD PROPHYLAXIS IN UNRELATED DONOR BMT
Authors: BELANGER C ESPEROUBOURDEAU H BORDIGONI P JOUET JP SOUILLET G MILPIED N TROUSSARD X KUENTZ M HERVE P REIFFERS J DEMEOCQ F DAURIAC C BLAISE D MICHALLET M FIERE D FREYCON F GRATECOS N RIO B LEBLOND V IFRAH N ATTAL M BERGERAT JP VILMER E PICO J RAFFOUX C CAUDRELIER P GLUCKMAN E
Citation: C. Belanger et al., USE OF AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY FOR GVHD PROPHYLAXIS IN UNRELATED DONOR BMT, Bone marrow transplantation, 11(4), 1993, pp. 293-297
INFLUENCE OF VARIOUS CONDITIONING REGIMENS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION FOR LEUKEMIA
Authors: DEVERGIE A SOCIE G ESPEROUBOURDEAU H RIBAUD P TRAINEAU R GLUCKMAN E
Citation: A. Devergie et al., INFLUENCE OF VARIOUS CONDITIONING REGIMENS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION FOR LEUKEMIA, Nouvelle revue francaise d'hematologie, 33(6), 1991, pp. 437-439
RECENT TREATMENTS OF APLASTIC-ANEMIA
Authors: GLUCKMAN E ESPEROUBOURDEAU H
Citation: E. Gluckman et H. Esperoubourdeau, RECENT TREATMENTS OF APLASTIC-ANEMIA, Nouvelle revue francaise d'hematologie, 33(6), 1991, pp. 507-510
Risultati: 1-14 |